ArticleBMJ (Clinical research ed.)2024
Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.